Caution In Markets Ahead Of Payrolls Data Release

Image source: Adobe Stock

Caution in Markets Ahead of Payrolls Data Release. 📊 U.S. stock futures suggest a subdued opening as investors await November payrolls data, a key economic report that may influence Federal Reserve policy and market direction. Federal Reserve Chair Jerome Powell’s recent remarks on the economy’s strength have tempered rate cut expectations, adding to today’s cautious sentiment. Benzinga reports.

🤖 AIZona: TSMC in talks with Nvidia for AI chip production in Arizona. Reuters reports.

🏗️ BillionPlant: Apple plans $1 billion manufacturing plant investment in Indonesia, minister says. Reuters reports.

📈 AirSurge: Southwest and American airlines raise sales outlooks, shares jump. CNBC reports.

⚡ VolkswagenStrikes: VW workers step up strikes to fight German plant closures. Yahoo Finance reports.

🚀 BroadGenAI: Broadcom unveils new tech to speed up custom chips amid rising GenAI demand. Reuters reports.

💻️ IntelBoard: Intel’s new board members offer clues about CEO search. MarketWatch reports.

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM Eastern Time)
Benzinga reports.

1. $UPC: Universe Pharmaceuticals
Total gain: +270.47%

2. $ZBAO: Zhibao Technology
Total gain: +80.39%

3. $ALBT: Avalon Globocare
Total gain: +76.69%

4. $GXAI: Gaxos.AI
Total gain: +51.4%

5. $JFBR: Jeffs Brands
Total gain: +47.82%

What Was the First Company with a $1 Billion Market Cap?

United States Steel Corporation was the world's first company to surpass the market capitalization mark of $1 billion dollars.
In the early 1900s, John Piermont Morgan wanted to do for steel what he had done in railroads. The only problem was that Andrew Carnegie controlled the biggest and most efficient producer of steel, Carnegie Steel. Morgan worked with Charles Schwab to convince Carnegie to sell his business into the new entity envisioned by Morgan, U.S. Steel. Carnegie, already pondering retirement, agreed to sell to the Morgan-headed trust for an overall price of about $492 million in stocks and bonds of the new company. Carnegie went on to focus on philanthropy while Schwab became the president of U.S. Steel.

📰 Read more

The closing price of the top three market percent gainers trading near or above $3 on December 5.

*All pricing and percent gains are based on regular market trading hours from 9:30am to 4:00pm Eastern Time

1. $RKDA: Arcadia Biosciences
Total gain: +96.51%
The company has announced a definitive securities exchange agreement to merge the two companies through an all-stock transaction. As part of the agreement, Arcadia will issue shares of its common stock to Roosevelt's partners at the transaction's closing in exchange for all of Roosevelt's equity interests. After the transaction is completed, Roosevelt's current equity owners are expected to hold approximately 90% of Arcadia's outstanding shares, while Arcadia's existing shareholders will own roughly 10%. These ownership percentages may be adjusted as outlined in the definitive agreement. Benzinga reports.

2. $PRFX: PainReform
Total gain: +72.01%
The company recently announced a 1-for-4 forward stock split, driving the stock price upward. Under this split, shareholders will receive four additional shares for every share they currently own. Although the total number of shares increases, the overall value of each shareholder's investment remains the same. The forward split is intended to improve liquidity and make the stock more accessible to investors, fueling its recent positive momentum. Benzinga reports.

3. $TARA: Protara Therapeutics
Total gain: +62.71%
The company announced results from its ongoing Phase 2 open-label ADVANCED-2 trial, which is evaluating intravesical TARA-002, an investigational cell-based therapy, in high-risk Non-Muscle Invasive Bladder Cancer (NMIBC) patients. The trial focuses on patients with carcinoma in situ (CIS ± Ta/T1) who are either Bacillus Calmette-Guérin (BCG)-unresponsive or BCG-naïve. The complete response (CR) rate was 72% (13/18) at six months and 70% (14/20) at any point during the trial. Notably, 100% (9/9) of patients who achieved a CR at three months maintained it through six months. Additionally, two out of three patients sustained a CR at nine months. Benzinga reports.

*Estimate and Actual numbers represent Earnings Per Share in US Dollars

KIRK: Kirkland's
3Q 2024
Before Market Open
Estimate: -0.270
Actual: N/A

GCO: Genesco
3Q 2025
Before Market Open
Estimate: 0.290
Actual: N/A

DOOO: BRP
3Q 2025
Before Market Open
Estimate: 0.500
Actual: 0.850

Time (ET) / Report / Period

8:30 am - U.S. employment report - November
8:30 am - U.S. unemployment rate - November
8:30 am - U.S. hourly wages - November

“The successful investor is usually an individual who is inherently interested in business problems.”

― Philip Fisher

Sourced in:
“Common Stocks and Uncommon Profits”, by Philip Fisher, published in 1958